Добірка наукової літератури з теми "Cervix uteri Cancer Victoria Prevention"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Зміст
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Cervix uteri Cancer Victoria Prevention".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Cervix uteri Cancer Victoria Prevention"
Vasilj, Ivan, Semra Cavaljuga, Marija Strnad, and Ariana Znaor. "Endometrial cancer epidemiology and prevention in Federation of Bosnia and Herzegovina, B&H." Bosnian Journal of Basic Medical Sciences 4, no. 4 (November 20, 2004): 63–65. http://dx.doi.org/10.17305/bjbms.2004.3364.
Повний текст джерелаMathur, Prashant, Krishnan Sathishkumar, Meesha Chaturvedi, Priyanka Das, Kondalli Lakshminarayana Sudarshan, Stephen Santhappan, Vinodh Nallasamy, Anish John, Sandeep Narasimhan, and Francis Selvaraj Roselind. "Cancer Statistics, 2020: Report From National Cancer Registry Programme, India." JCO Global Oncology, no. 6 (September 2020): 1063–75. http://dx.doi.org/10.1200/go.20.00122.
Повний текст джерелаZulfa, Lathifah Dzakiyyah, Dessyani Salim, and Abigail Tirza Silalahi. "Role of Tomato (Solanum lycopersicum) in Management and Prevention of Four Most Common Cancer in Indonesia." SCRIPTA SCORE Scientific Medical Journal 3, no. 2 (February 28, 2022): 186–91. http://dx.doi.org/10.32734/scripta.v3i2.5522.
Повний текст джерелаMoreira, Rita De Cássia Rocha, Ludmilla Oliveira Souza, Manoela De Assis Silva Carvalho, and Scheila Conceição Sacramento Saldanha. "Perfil epidemiológico do câncer de colo uterino no município de feira de santana, Bahia, Brasil." Revista de Enfermagem UFPE on line 3, no. 4 (September 19, 2009): 998. http://dx.doi.org/10.5205/reuol.581-3802-1-rv.0304200926.
Повний текст джерелаMomenimovahed, Zohre, and Hamid Salehiniya. "Incidence, mortality and risk factors of cervical cancer in the world." Biomedical Research and Therapy 4, no. 12 (December 8, 2017): 1795. http://dx.doi.org/10.15419/bmrat.v4i12.386.
Повний текст джерелаRees, Margaret, Roberto Angioli, Robert L. Coleman, Rosalind M. Glasspool, Francesco Plotti, Tommaso Simoncini, and Corrado Terranova. "European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis." International Journal of Gynecologic Cancer 30, no. 4 (February 11, 2020): 428–33. http://dx.doi.org/10.1136/ijgc-2020-001217.
Повний текст джерелаKim, Jinhee, Donghwan Lee, Kyung-Bok Son, and SeungJin Bae. "The Burden of Cervical Cancer in Korea: A Population-Based Study." International Journal of Environmental Research and Public Health 17, no. 17 (August 30, 2020): 6308. http://dx.doi.org/10.3390/ijerph17176308.
Повний текст джерелаDemissie, Birhanu Wondimeneh, Gedion Asnake Azeze, Netsanet Abera Asseffa, Eyasu Alem Lake, Befekadu Bekele Besha, Kelemu Abebe Gelaw, Taklu Marama Mokonnon, Natnael Atnafu Gebeyehu, and Mohammed Suleiman Obsa. "Communities’ perceptions towards cervical cancer and its screening in Wolaita zone, southern Ethiopia: A qualitative study." PLOS ONE 17, no. 1 (January 7, 2022): e0262142. http://dx.doi.org/10.1371/journal.pone.0262142.
Повний текст джерелаBadar, F., and N. Anwar. "SP3-28 Is vaccination against the human papillomavirus for prevention of the cervix uteri cancer indicated in Pakistan where there is no Pap smear cervical cancer screening program-a public health perspective?" Journal of Epidemiology & Community Health 65, Suppl 1 (August 1, 2011): A416. http://dx.doi.org/10.1136/jech.2011.142976o.28.
Повний текст джерелаHussain, Syed Md Akram. "Comprehensive update on cancer scenario of Bangladesh." South Asian Journal of Cancer 02, no. 04 (October 2013): 279–84. http://dx.doi.org/10.4103/2278-330x.119901.
Повний текст джерелаДисертації з теми "Cervix uteri Cancer Victoria Prevention"
張雨萍 and Yu-ping Cheung. "Overview of cost-effectiveness of cervical cancer screening: a systematic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B4170969X.
Повний текст джерелаChoi, Cheuk-wai, and 蔡卓偉. "Modeling the potential impact of HPV vaccination on Hong Kong's cervical cancer burden." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/206747.
Повний текст джерелаpublished_or_final_version
Public Health
Doctoral
Doctor of Philosophy
Fallala, Muriel Selma. "Cervical cancer screening : safety, acceptability, and feasibility of a single-visit approach in Bulawayo, Zimbabwe." Thesis, Stellenbosch : Stellenbosch University, 2014. http://hdl.handle.net/10019.1/97187.
Повний текст джерелаOBJECTIVE: The purpose of the study was to assess the safety, acceptability and feasibility of Visual Inspection with Acetic Acid and Cervicography (VIAC) followed by Cryotherapy or Loop Electrical Excision Procedure (LEEP) at a single visit for prevention of cancer of the cervix in Bulawayo, Zimbabwe. STUDY DESIGN: The study was descriptive using retrospective data extracted from electronic medical records of women attending the VIAC clinic at United Bulawayo Hospital in the period 1st February2010 to 31st December2012.Over 24 months 4641 women visited the clinic and were screened for cervical cancer using VIAC. If positive and eligible, cryotherapy or LEEP was offered immediately. Treated women were followed up at 3months and 1 year. RESULTS: The VIAC test positive rate was 10.8%.Of those eligible,17.0% received immediate cryotherapy, 44.1%received immediate LEEP, 1.9% delayed treatment and 37.0% were referred to a gynaecologist. No major complications were recorded after cryotherapy or LEEP. Among those treated99.5% expressed satisfaction with their experience. Only 3.2% of those treated at the clinic were VIAC positive one year later. The service was shown to be feasible to sustain over time with the necessary consumables. There were no service-related treatment postponements and the clinic staff and facility were able to meet the demand for the service. CONCLUSION: A single visit approach using VIAC, followed by cryotherapy or LEEP proved to be safe, acceptable and feasible in an urban African setting in Bulawayo, Zimbabwe.
AFRIKAANSE OPSOMMING: Geen opsomming beskikbaar.
許素安 and So-on Hui. "An education intervention to improve cervical smear screening attendance rate among Hong Kong women." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B40720731.
Повний текст джерелаZhao, Yingzi, and 赵缨姿. "Immunogenicity and safety of two human papillomavirus vaccines for cervical cancer among Asian female populations : a systematic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193778.
Повний текст джерелаpublished_or_final_version
Public Health
Master
Master of Public Health
Wong, Chi-kuan Ada, and 黃智君. "Knowledge and perception on cervical cancer screening and prevention among nursing graduates in Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46942956.
Повний текст джерелаBeaumont, Nerida. "The relative importance of barriers to cervical cancer screening in older women : A review of 140 women and their pap smear providers." Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 1999. https://ro.ecu.edu.au/theses/1218.
Повний текст джерелаKo, Woon Yee Jessie. "A source-based inquiry of optimistic bias and its impact on health-related behaviors : implications for cervical cancer prevention communications." HKBU Institutional Repository, 2011. http://repository.hkbu.edu.hk/etd_ra/1283.
Повний текст джерелаJensen-Ross, Christine, and University of Lethbridge School of Health Sciences. "Cervical screening among Southern Alberta First Nations women living off-reserve." Thesis, Lethbridge, Alta. : University of Lethbridge, School of Health Sciences, 2006, 2006. http://hdl.handle.net/10133/400.
Повний текст джерелаxii, 223 leaves ; 29 cm.
Vale, Diama Bhadra Andrade Peixoto do 1978. "Avaliação do rastreamento do câncer do colo do útero na estratégia de saúde da família no município de Amparo, São Paulo, Brasil." [s.n.], 2010. http://repositorio.unicamp.br/jspui/handle/REPOSIP/310559.
Повний текст джерелаDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-16T19:33:51Z (GMT). No. of bitstreams: 1 Vale_DiamaBhadraAndradePeixotodo_M.pdf: 6577919 bytes, checksum: 70e533105be682a7083418f3bad0b3a0 (MD5) Previous issue date: 2010
Resumo: O rastreamento do câncer do colo do útero no Brasil não tem sido efetivo em reduzir as altas taxas de incidência e mortalidade desta neoplasia, apesar de o Ministério da Saúde ter estabelecido há mais de 20 anos as normas definindo a população-alvo e a periodicidade dos controles. A territorialização e o cadastramento das famílias pelo Programa de Saúde da Família favorecem a ruptura com o padrão oportunístico do rastreamento e com a identificação das mulheres que nunca fizeram o exame citológico ou estão há mais de três anos sem fazê-lo. Este estudo analisou se o rastreamento do câncer do colo do útero avançou no sentido de seguir as recomendações vigentes, ao longo de sete anos de implantação do Programa de Saúde da Família em Amparo, município do interior de São Paulo, referência em ações de atenção básica. Os objetivos foram verificar a variação da frequência dos exames realizados em função do intervalo desde o último controle, do grupo etário, da cobertura das ações de rastreamento e dos exames realizados em excesso. O estudo foi longitudinal e retrospectivo. Os sujeitos foram todas as mulheres usuárias do Sistema Único de Saúde que realizaram o exame citológico de rastreamento de janeiro de 2001 a dezembro de 2007. Para análise estatística, foi utilizado o teste de qui-quadrado modificado por Cochran-Armitage para tendência. A periodicidade anual manteve-se alta no período do estudo, variando entre 51,2% e 59,7% do total dos controles realizados. Houve aumento estatisticamente significante, ainda que discreto, em números relativos, dos exames realizados com intervalo de dois anos ou mais desde o último controle, como também houve redução das mulheres realizando exame pela primeira vez. A distribuição de exames tendeu a aumentar no grupo etário 40-59 anos e a diminuir no grupo etário com mais de 60 anos. Os percentuais de exames em excesso variaram de 61,2% a 65,5%. Concluindo, a qualificação do rastreamento do câncer do colo do útero foi discreta e não modificou o padrão oportunístico dos controles. O Programa da Saúde da Família, ainda que possa ser uma estratégia com potencial para organizar o rastreamento do câncer do colo do útero no Brasil, não mostrou impactos evidentes neste sentido. Os agentes comunitários de saúde, componentes das equipes de saúde da família, podem atuar no sentido de identificar as mulheres-alvo que não estão realizando regularmente os controles periódicos. Portanto é essencial capacitá-los para cumprir este papel
Abstract: Cervical cancer screening in Brazil has failed to reduce the high incidence and mortality rates associated with this disease despite the fact that the Brazilian Ministry of Health established regulations defining the target population and the periodicity of screening tests over 20 years ago. The territorial distribution and the registration of families in the Family Health Program should interrupt the opportunistic screening pattern, identifying women who have never been screened or who were last screened over three years previously. This study evaluated whether any progress had been achieved in cervical cancer screening in terms of compliance with the current recommendations over the period of seven years since implementation of the Family Health Program in Amparo, a township in the state of São Paulo and a reference in primary healthcare. The objectives of this longitudinal, retrospective study were to analyze the variation in the frequency of testing in accordance with the interval since previous screening, age group, the coverage provided by the screening actions and the extent of unwarranted testing. The subjects consisted of all the women using the Brazilian National Health Service who had been submitted to a cervical smear test between January 2001 and December 2007. The Cochran-Armitage test for trend was used in the statistical analysis. Annual periodicity remained high throughout the observation time of the study, ranging from 51.2% to 59.7% of the total number of screening tests performed. There was a statistically significant increase in the tests performed within an interval of two years or more since the previous screening; however, this increase was modest in relative numbers. In addition, a reduction was found in the number of women undergoing testing for the first time. The distribution of tests according to age group showed a tendency towards an increase in the 40-59 year age group and a decrease in the over-60s age group. The percentage of unwarranted tests ranged from 61.2% to 65.5%. In conclusion, the improvement in cervical cancer screening was slight and was insufficient to alter the opportunistic pattern of screening. Although Brazil?s Family Health Program has the potential to organize cervical cancer screening in the country, there is no evidence of any significant change at this moment. The community healthcare agents working in the Family Health Program teams could implement measures for identifying target women who are not being submitted to regular screening; hence they should be trained to perform this role
Mestrado
Oncologia Ginecológica e Mamária
Mestre em Ciências da Saúde
Книги з теми "Cervix uteri Cancer Victoria Prevention"
Preventing cervical cancer: What every woman should know. St. Albans, Herts, England: Altman, 2007.
Знайти повний текст джерелаGebbie, Kristine M. Washington cancer control plan: Smoking-related, breast, and cervical cancer. Olympia, Wash: Washington State Dept. of Health, Office of Heart Disease and Cancer Prevention, 1991.
Знайти повний текст джерелаPennsylvania. General Assembly. Joint State Government Commission. Cervical cancer in Pennsylvania: Easing the burden. Harrisburg, Pa: Joint State Government Commission, 2004.
Знайти повний текст джерелаGong jing ai fang zhi zhi nan: Gongjing ai fangzhi zhinan. Wuhan Shi: Hubei ke xue ji shu chu ban she, 2015.
Знайти повний текст джерелаAhuja, Maninder. Precancerous lesions of cervix: Prevention, early diagnosis and management. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd, 2014.
Знайти повний текст джерелаJulian, Chomet, ed. Cervical cancer: All you and your partner need to know about its prevention, detection and treatment. Wellingborough, England: Grapevine, 1989.
Знайти повний текст джерелаVaccines for the prevention of cervical cancer. Oxford: Oxford University Press, 2010.
Знайти повний текст джерелаE, Rohan Thomas, and Shah Keerti V, eds. Cervical cancer: From etiology to prevention. Dordrecht: Kluwer Academic, 2004.
Знайти повний текст джерелаVermont. Dept. of Health. Eradication of cervical cancer: Report to the Legislature on Act 110 (2006 ADJ session). Burlington, Vt: Vermont Dept. of Health, 2007.
Знайти повний текст джерелаVermont. Dept. of Health. Eradication of cervical cancer: Report to the Legislature on Act 110 (2006 ADJ session). Burlington, Vt: Vermont Dept. of Health, 2007.
Знайти повний текст джерела